Involvement of nuclear factor κB in c-myc induction by tubulin polymerization inhibitors

Molecular Pharmacology

Volumn 59, Issue 5, 2001, Pages 1165-1170

  Bourgarel Rey, V ^a   Vallee, S ^a   Rimet, O ^a   Champion, S ^a   Braguer, D ^a   Desobry, A ^a   Briand, C ^a   Barra, Y ^a,b  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; MYC PROTEIN; THYMIDINE KINASE; VINBLASTINE;

APOPTOSIS; ARTICLE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME REGULATION; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL;

EID: 0035032028     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.5.1165     Document Type: Article

References (42)

1. A far upstream element stimulates c-myc expression in undifferentiated leukemia cells
2. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
3. Activate NF-kappa B or die?
4. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts
5. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation
6. Animal cell shape changes and gene expression
7. Molecular themes in oncogenesis
8. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression
9. Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used
10. Effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells
11. Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs
12. I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain
13. Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism
14. Repeated CT-elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters
15. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF κB
16. Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs
17. The MYC dualism in growth and death
18. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2′,3′,4′ -trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: Protection by Bcl-2 and Bcl-X(L) and cell cycle arrest
19. Hyperphosphorylation of Tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells
20. Regulatory elements that modulate expression of human c-myc
21. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B
22. E1A-dependent transactivation of the human c-myc promoter is mediated by the E2F factor
23. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma
24. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells
25. Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
26. Function of the c-Myc oncoprotein
27. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and growth factor
28. Disruption of microtubule network in human monocytes induces expression of interleukin-1 but not that of interleukin-6 nor tumor necrosis factor-α. Involvement of protein kinase A stimulation
29. Taxane-mediated gene induction is independent of microtubule stabilization: Induction of transcription regulators and enzymes that modulate inflammation and apoptosis
30. Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
31. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
32. Yin-yang 1 activates the c-myc promoter
33. Cytoskeletal control of gene expression: Depolymerization of microtubules activates NF-kappa B
34. Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production
35. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B posttranslational mechanism
36. Activation of microtubule-associated protein kinase by microtubule disruption in quiescent rat 3Y1 cells
37. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
38. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways
39. The many roles of c-Myc in apoptosis
40. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways
41. 2-terminal kinase activation in response to changes in the microtubule cytoskeleton
42. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism